TORNTPHARM - Swing Trade Analysis with AI Signals
Last Updated Time : 20 Dec 25, 07:02 am
Back to Swing Trade ListSwing Trade Rating: 3.7
| Stock Code | TORNTPHARM | Market Cap | 1,28,614 Cr. | Current Price | 3,800 ₹ | High / Low | 3,882 ₹ |
| Stock P/E | 60.2 | Book Value | 250 ₹ | Dividend Yield | 0.85 % | ROCE | 27.8 % |
| ROE | 26.2 % | Face Value | 5.00 ₹ | DMA 50 | 3,704 ₹ | DMA 200 | 3,494 ₹ |
| Chg in FII Hold | -0.17 % | Chg in DII Hold | 0.63 % | PAT Qtr | 606 Cr. | PAT Prev Qtr | 551 Cr. |
| RSI | 52.8 | MACD | 21.6 | Volume | 1,25,995 | Avg Vol 1Wk | 1,45,516 |
| Low price | 2,886 ₹ | High price | 3,882 ₹ | PEG Ratio | 2.48 | Debt to equity | 0.25 |
| 52w Index | 91.8 % | Qtr Profit Var | 31.8 % | EPS | 62.3 ₹ | Industry PE | 30.6 |
📊 TORNTPHARM is currently trading at ₹3,800, close to its 52-week high of ₹3,882, reflecting strong bullish momentum. The stock is above both its 50 DMA (₹3,704) and 200 DMA (₹3,494), confirming an uptrend. RSI at 52.8 suggests balanced momentum, while MACD at 21.6 supports positive sentiment. The optimal entry price would be near ₹3,700–₹3,750, closer to support levels. If already holding, consider exiting around ₹3,850–₹3,880, near resistance zones.
✅ Positive
- 📈 Strong ROCE (27.8%) and ROE (26.2%), showing excellent capital efficiency
- 💰 Dividend yield of 0.85%, providing modest shareholder return
- 📊 EPS at ₹62.3, reflecting consistent profitability
- 📈 Quarterly PAT increased from ₹551 Cr. to ₹606 Cr., a 31.8% growth
- 📊 Trading above both 50 DMA and 200 DMA, confirming bullish technical strength
⚠️ Limitation
- 📉 High P/E ratio (60.2) compared to industry average (30.6), indicating overvaluation
- 📊 PEG ratio at 2.48, suggesting expensive valuation relative to growth
- 📉 Dividend yield remains low compared to sector peers
- 📉 Volume (1,25,995) below weekly average (1,45,516), showing weaker participation
🚨 Company Negative News
- 📉 FII holding decreased by -0.17%, showing reduced foreign investor confidence
- 📉 Stock trading near its 52-week high may limit short-term upside potential
🌟 Company Positive News
- 📈 Strong quarterly profit growth (+31.8%) highlights operational improvement
- 📊 DII inflows (+0.63%) provide stability against FII outflows
🏭 Industry
- 📊 Industry P/E at 30.6 is much lower, suggesting TORNTPHARM trades at a premium
- 🌐 Pharma sector remains resilient with long-term demand for healthcare and specialty drugs
📌 Conclusion
TORNTPHARM is a moderately strong swing trade candidate. While fundamentals show profitability and growth, high valuation limits upside. Entry is best near ₹3,700–₹3,750, while exit should be considered around ₹3,850–₹3,880. Traders should monitor RSI and volume trends closely before committing.
I can also outline TORNTPHARM’s medium-term support and resistance levels to help you track positional trades alongside swing opportunities. Would you like me to prepare that?
Back to Swing Trade ListNIFTY 50 - Today Top Swing Trade Stock Picks
NEXT 50 - Today Top Swing Trade Stock Picks
MIDCAP - Today Top Swing Trade Stock Picks
SMALLCAP - Today Top Swing Trade Stock Picks